Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France

Clinical trial NCT06421311 · TERMINATED

Trial details

NCT number: NCT06421311
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Study type: OBSERVATIONAL

Urothelial Carcinoma

Start date: 2024-07-30
Primary completion: 2025-04-04
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.